Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$63.15 - $72.88 $11,998 - $13,847
190 New
190 $13.1 Million
Q2 2023

Aug 03, 2023

BUY
$76.01 - $86.7 $29,567 - $33,726
389 Added 2.62%
15,257 $1.18 Billion
Q1 2023

May 09, 2023

BUY
$77.31 - $88.08 $1.15 Million - $1.31 Million
14,868 New
14,868 $1.23 Billion

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $115B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Great Lakes Retirement, Inc. Portfolio

Follow Great Lakes Retirement, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Lakes Retirement, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Great Lakes Retirement, Inc. with notifications on news.